What the Future Holds | GenomeWeb

What the Future Holds

Now that US President Barack Obama has won a second term, some are wondering how that second term may affect science budgets.

"Having an Obama administration versus a Romney administration may lead to some differences, but for the most part, I think things haven't changed much from where they were a week ago," says Matt Hourihan, the R&D budget and policy program director at the American Association for the Advancement of Science, to LiveScience.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.